Error message
You must have JavaScript and cookies enabled in your browser to flag content.Warning message
Missing Feeds plugin FeedsJSONPathParser. Please contact your site administrator.
This year’s recipients were indeed distinguished leaders in their fields and have dedicated their careers to improve diagnosis, outcomes, and quality of life as well advancing personalized therapy for patients...
"We all need to stay informed and engaged on the topic of AI in order to be the best advocates for ourselves, our profession, and our patients."
At a time when we are being asked, in every aspect of our work, to do more with less, we can expect streamlined, efficient, pragmatically designed clinical trials to play an increasingly important role in our...
Following the ASCO Annual Meeting, the conversations in the news, on social media, and in the hallways of our institutions tend to be dominated by advances in the field—promising new treatments, genetic...
Dr. Bilal Anouti shares what you need to know about open access publications, based on his experience participating in the ASCO Journals Editorial Fellowship.
Whether you participate in person in Chicago, watch sessions online, or keep up with the meeting outcomes and conversations on social media (or any combination of these), I hope the ASCO Annual Meeting leaves...
"If we can provide chemotherapy services through a tele-chemotherapy model at smaller rural centers, why can’t we do the same for clinical trials?" asks Dr. Sabe Sabesan.
Conquer Cancer, the ASCO Foundation, is deeply invested in helping investigators build and sustain their research careers, starting with that first crucial grant.Â
"Cancer research relevant to LMICs is a necessity, not a luxury," writes Dr. Khalid El Bairi, and early-career oncologists in LMIC settings can advance cancer research in their communities.
Pages